Publications by authors named "F Kullmann"

Claim this Profile
I
Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer - A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial.
Kathrin Heinrich, Sebastian Stintzing, Ludwig Fischer von Weikersthal, Thomas Decker, Alexander Kiani, Frank Kullmann

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFIRI with cetuximab or bevacizumab in RAS wild-type metastatic colorectal cancer: Refining first-line treatment selection by combining clinical parameters: A post hoc analysis of the randomized open-label phase III trial FIRE-3/AIO KRK0306.
Julian Walter Holch, Alexander J Ohnmacht, Sebastian Stintzing, Kathrin Heinrich, Lena Weiss, Frank Kullmann

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancer.
Lena Weiss, Sebastian Stintzing, Arndt Stahler, C Benedikt Westphalen, Ludwig Fischer von Weikersthal, Frank Kullmann

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying the trade-offs between renewable energy visibility and system costs.
Tsamara Tsani, Tristan Pelser, Romanos Ioannidis, Rachel Maier, Ruihong Chen, Felix Kullmann

Nat Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)": [ESMO Open 7 (2024) 100552].
I Hartlapp, D Valta-Seufzer, J T Siveke, H Algül, E Goekkurt, F Kullmann

ESMO Open· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis